A new national survey has found career stability and funding are two key factors turning young scientists away from research.
The world’s most advanced artificial heart, including a pipeline of transformative, next-generation cardiac technologies, are set to be developed and commercialised by a Monash University-led consortium.
Trace the increasingly blurred line between man and machine in the world of transhumanism on our “What Happens Next?” podcast.
It’s argued that building research capacity helps clinicians to provide better care, and health outcomes, for their patients in rural and remote areas.
Little has been said about the potential use and misuse of generative AI, particularly in medicine and healthcare.
With an unavoidable reduction in research output, women are forced out of science at earlier stages in their careers.
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
For Dr Faezeh Marzbanrad, engineering a solution for more intuitive foetal heart monitoring was born out of personal experience.
Researchers are working to transform conventional CCTV cameras into autonomously intelligent systems that can detect crimes in real time.
The new Neuromedicines Discovery Centre (NDC) aims to develop psychiatric drugs and approaches to psychedelic-assisted psychotherapies for common mental illnesses.
Researchers are exploring the medical frontier of psychedelics, and their use in facilitating psychotherapy for common mental illnesses.
Could psychedelic drugs provide the next big breakthrough in psychiatry? This episode of the ‘What Happens Next?’ podcast considers the regulatory, cultural and scientific aspects of psychedelic treatment for mental illness – and how innovation in this area could improve the lives of millions of people.
A nationwide study reveals the ways school psychologists and counsellors adapted to overcome the challenges of pandemic-related restrictions.
Finding a way out of the COVID-19 crisis will firstly require more urgent and coordinated investment in medical innovation.
From dementia to depression to drug addiction, artificial brain stimulation has been hailed as a landmark medical technology for the future. But safeguards are needed if we want the benefits without the risks.
Friendships, marriages and business partnerships continue to be forged at Monash.
How can a university make sure that people, beyond its students and staff, benefit from its knowledge and presence?
Promoting excellence in pharmacy teaching will impact the healthcare of communities for years to come.
Monash's most recent cohort of Fulbright, Rhodes and Schwarzman scholars share their passions and plans for the future.
A device being trialled globally that measures the heart rate of the mother and her foetus is moving care to an outpatient setting.
With Melbourne’s population continuing to boom, urban planners and academics have a vision for the city to become a network of connected communities where people will be able to walk or cycle to amenities.
The $543 million Victorian Heart Hospital will be Australia's first dedicated facility to tackle the country's No.1 killer.
Low-dose aspirin has no benefit in prolonging a life free of disability, or substantially reducing the risk of having a first heart attack or stroke, study finds.
The long-touted links to Tullamarine and Monash have again been revived, but questions remain over the plans.
Dummy text